{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-25",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "64380-714",
      "generic_name": "tenofovir disoproxil fumarate",
      "labeler_name": "Strides Pharma Science Limited",
      "brand_name": "TENOFOVIR DISOPROXIL FUMARATE",
      "active_ingredients": [
        {
          "name": "TENOFOVIR DISOPROXIL FUMARATE",
          "strength": "300 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "64380-714-04",
          "description": "30 TABLET in 1 BOTTLE (64380-714-04)",
          "marketing_start_date": "20180126",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Strides Pharma Science Limited"
        ],
        "rxcui": [
          "349251"
        ],
        "spl_set_id": [
          "bcd3120b-60f6-41d8-a512-ed4a62c836b4"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0364380714040"
        ],
        "unii": [
          "OTT9J7900I"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "961e32f0-f1e2-4d34-ba55-7cf8355c060d",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20180126",
      "product_id": "64380-714_961e32f0-f1e2-4d34-ba55-7cf8355c060d",
      "application_number": "ANDA090742",
      "brand_name_base": "TENOFOVIR DISOPROXIL FUMARATE",
      "pharm_class": [
        "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
        "Nucleosides [CS]"
      ]
    }
  ]
}